1. Home
  2. NKGN vs DLPN Comparison

NKGN vs DLPN Comparison

Compare NKGN & DLPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKGN
  • DLPN
  • Stock Information
  • Founded
  • NKGN 2017
  • DLPN N/A
  • Country
  • NKGN United States
  • DLPN United States
  • Employees
  • NKGN N/A
  • DLPN N/A
  • Industry
  • NKGN Biotechnology: Biological Products (No Diagnostic Substances)
  • DLPN Other Consumer Services
  • Sector
  • NKGN Health Care
  • DLPN Consumer Discretionary
  • Exchange
  • NKGN Nasdaq
  • DLPN Nasdaq
  • Market Cap
  • NKGN 14.1M
  • DLPN 15.8M
  • IPO Year
  • NKGN N/A
  • DLPN N/A
  • Fundamental
  • Price
  • NKGN $0.28
  • DLPN $0.67
  • Analyst Decision
  • NKGN
  • DLPN
  • Analyst Count
  • NKGN 0
  • DLPN 0
  • Target Price
  • NKGN N/A
  • DLPN N/A
  • AVG Volume (30 Days)
  • NKGN 491.9K
  • DLPN 35.6K
  • Earning Date
  • NKGN 11-12-2024
  • DLPN 11-12-2024
  • Dividend Yield
  • NKGN N/A
  • DLPN N/A
  • EPS Growth
  • NKGN N/A
  • DLPN N/A
  • EPS
  • NKGN N/A
  • DLPN N/A
  • Revenue
  • NKGN N/A
  • DLPN $48,891,700.00
  • Revenue This Year
  • NKGN N/A
  • DLPN $19.92
  • Revenue Next Year
  • NKGN N/A
  • DLPN $8.88
  • P/E Ratio
  • NKGN N/A
  • DLPN N/A
  • Revenue Growth
  • NKGN N/A
  • DLPN 16.54
  • 52 Week Low
  • NKGN $0.28
  • DLPN $0.51
  • 52 Week High
  • NKGN $5.10
  • DLPN $2.00
  • Technical
  • Relative Strength Index (RSI)
  • NKGN 23.68
  • DLPN 51.03
  • Support Level
  • NKGN $0.36
  • DLPN $0.60
  • Resistance Level
  • NKGN $0.44
  • DLPN $0.72
  • Average True Range (ATR)
  • NKGN 0.04
  • DLPN 0.09
  • MACD
  • NKGN 0.00
  • DLPN 0.01
  • Stochastic Oscillator
  • NKGN 2.63
  • DLPN 80.95

About NKGN NKGen Biotech Inc.

NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

Share on Social Networks: